Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05050240 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

BATokines as Biomarkers of Brown Fat in Humans

StatusActive, Not Recruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Minor Re-verified, no change to tracked fieldsv9
  2. Notable Primary and study completion dates: Dec 31, 2024 to Dec 31, 2026v8
  3. Notable Primary and study completion dates: Dec 31, 2023 to Dec 31, 2024v7
  4. Minor Trial status: Recruiting to Active, Not Recruiting
    • Site details revised
    v6
  5. Notable Trial status: Active, Not Recruiting to Recruitingv5 Show 5 more changesShow less
    • Primary and study completion dates: Oct 1, 2022 to Dec 31, 2023
    • Interventions: Cooling Vest Procedure (Other) to Cooling Vest Procedure (Other), Fasting overnight (Other)
    • Eligibility criteria revised
    • Site details revised
    • Study arms: 1 to 2
Show 3 earlier versionsHide 3 earlier versions
  1. Notable Primary completion date: Apr 1, 2022 to Oct 1, 2022
    • Trial status: Enrolling by Invitation to Active, Not Recruiting
    • Study completion date: Jun 1, 2022 to Oct 1, 2022
    v4
  2. Minor Trial status: Recruiting to Enrolling by Invitation
    • Primary completion date: Dec 20, 2021 to Apr 1, 2022
    • Site details revised
    v3
  3. Notable Trial status: Not Yet Recruiting to Recruiting
    • Study sites: 0 to 1
    • Start date changed from estimate of Sep 20, 2021 to Oct 12, 2021
    v2
  1. Minor Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Brown adipose tissue (BAT) burns excess calories to produce heat in response to environmental cold. Rapidly growing evidence from rodent and human studies suggests that the presence and activation of brown fat are far more beneficial for whole body metabolism and cardiometabolic health than previously appreciated. Despite the clear associations between brown fat and metabolic health, we lack both: cost-effective means of detecting brown fat in humans as well as comprehensive insights into how brown fat facilitates metabolism on a molecular level in humans. Emerging evidence suggests that the benefits of brown fat activation are mediated, at least in part, by secretion of specific molecules into the bloodstream which signal to metabolically active organs such as skeletal muscle, liver and brain. A number of these so-called brown adipokines (or BATokines) have now been discovered in mice and shown to positively impact glucose homeostasis, liver and muscle function. Human deep-neck brown fat biopsies reveal that \>1000 molecules could potentially be secreted from brown fat, and \>400 are released by human brown fat cells in a dish, representing a major opportunity for discovery of high translational value. Here, we aim to identify a screen of first potential blood biomarkers of brown fat in healthy young humans. This will be achieved by analyzing plasma proteins in subjects with 'inactive brown fat' (warm) and 'activated brown fat' (3-hr cold exposure, cooling vests) using high-throughput technologies (SOMAscan and O-link) to identify temperature-sensitive brown fat-enriched molecules. This preliminary data will guide a larger follow up study in which we envision studying lean and obese (insulin sensitive and insulin resistant) subjects of various age groups and race/ethnicity. Human BATokines identified here will become primary targets for manipulation in experimental animals to assess their therapeutic potential against obesity, T2D, and associated diseases. Additionally, since current methods of brown fat detection in human rely on deep neck biopsies or costly 18-FDG-PET/CT scans, identification of blood biomarkers of brown fat would offer a cost-effective and non-invasive alternative for prediction of metabolic health in humans.
Trial Details
NCT Number NCT05050240
Lead Sponsor Rockefeller University
Collaborators: Beth Israel Deaconess Medical Center
Conditions
(from sponsor)
Healthy Lifestyle
Enrollment 20 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov